Clinical Trial

Selective CT for Anticoagulated Head Injured Patients

Study acronym: Can-SCAHn
Recruiting
View on ClinicalTrials.gov →
Summary
The goal is to derive and a clinical decision rule for safe exclusion of traumatic brain injury without neuroimaging in head-injured ED patients who take anticoagulant medications. The objectives are to: 1. Derive and externally validate a new highly sensitive and maximally specific clinical decision rule for the exclusion of traumatic brain injury in head-injured ED patients who take anticoagulant medications; and, 2. Estimate the sensitivity and specificity of existing head injury clinical decision rules in head-injured ED patients who take anticoagulant medications.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-05-05; most recent amendment 2026-04-11.
Trial Details
NCT Number NCT05364749
Lead Sponsor Dr. Kerstin de Wit
Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions Head Injury, Traumatic Brain Injury, Intracranial Hemorrhage, Traumatic, Blunt Head Injury
Enrollment 4,000 participants
Start Date 2022-02-01
Primary Completion 2026-03-15 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-14